Considering that HLA-G is limited to immune-privileged tissues and is almost undetectable in normal cells, chemotherapy-induced high expression of HLA-G in tumor cells would cause a further reduction in the damaging effects of HLA-G CAR-NK on normal tissues. The gene discussed is HLA-G; the disease is neoplasm.